SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-163695
Filing Date
2021-05-17
Accepted
2021-05-17 16:14:54
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d277349d10q.htm 10-Q 422374
2 EX-10.10 d277349dex1010.htm EX-10.10 22629
3 EX-31.1 d277349dex311.htm EX-31.1 10961
4 EX-31.2 d277349dex312.htm EX-31.2 10999
5 EX-32.1 d277349dex321.htm EX-32.1 3226
6 EX-32.2 d277349dex322.htm EX-32.2 3264
  Complete submission text file 0001193125-21-163695.txt   3647900

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nexi-20210331.xml EX-101.INS 630276
8 XBRL TAXONOMY EXTENSION SCHEMA nexi-20210331.xsd EX-101.SCH 37735
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nexi-20210331_cal.xml EX-101.CAL 36530
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nexi-20210331_def.xml EX-101.DEF 196417
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20210331_lab.xml EX-101.LAB 370061
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20210331_pre.xml EX-101.PRE 284136
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 21930770
SIC: 2834 Pharmaceutical Preparations